What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

ImpediMed

The world leader in the development and distribution of medical devices utilizing bioimpedance spectroscopy (BIS).

04/27/2026

There’s a difference between screening for lymphedema—and having a plan to act on what you find.

Leading programs are moving beyond one-time measurements toward a more consistent approach to surveillance:

• Establish a baseline
• Monitor routinely
• Act on early change
• Treat before progression

Because when lymphedema is identified at the subclinical stage, intervention is simpler—and in many cases, progression can be avoided.

If you’re working on building or refining this kind of approach, we’ll be at both ASBrS and ALA this month and would welcome the conversation.

—
Find us here:

📍 ASBrS 2026 | Seattle, WA | April 29 – May 3 | Booth 308

📍 ALA Conference 2026 | Cairns, Australia | May 1 – 3
—

If you’d like to connect or schedule time:
🔗 https://www.impedimed.com/about/contact/

04/22/2026

A “wait and see” approach doesn’t work for lymphedema.

In this interview with CURE®, Dr. Sheri Prentiss shares how her own experience with breast cancer-related lymphedema reshaped her view of survivorship care — and why early risk assessment matters.

Symptoms can take months or even years to appear. By the time they’re visible, the impact on quality of life, function, and long-term management can already be significant.

Shifting toward earlier assessment and shared decision-making isn’t just a clinical change — it changes the trajectory of survivorship.

Read the full article: https://www.impedimed.com/expert-dr-sheri-prentiss-discusses-early-lymphedema-risk-assessment/

04/17/2026

When body composition changes over time, the question isn’t just what changed—it’s how to interpret it.

Fluid shifts can occur early and can influence how changes in fat and muscle appear, especially when tracking progress longitudinally.

That’s why separating intracellular and extracellular fluid is important—so changes in tissue can be understood in the right context, not in isolation.

👉 Learn how BIS supports more precise body composition analysis:
https://www.impedimed.com/products/tissue-fluid-applications/body-composition-analysis/

04/13/2026

Lymphedema care is becoming more proactive—and more precise.

We were in Columbus last week at the World Symposium for Lymphedema Surgery, where the focus is on what it takes to prevent, identify, and treat lymphedema earlier—across surgery, therapy, and long-term survivorship care.

As surgical approaches continue to advance, there’s increasing emphasis on how patients are monitored over time, and how early physiologic changes can inform intervention before symptoms progress.

04/11/2026

In aesthetic medicine, results are everything—but they’re not always easy to prove.

Clients can be losing weight without improving body composition. They can look the same in photos while something meaningful is changing underneath. And when progress isn’t clear, it’s harder to keep clients engaged and committed to treatment.

That’s a big part of the conversation at Medical Spa Show this year—how practices are bringing more objective insight into consultations, treatment plans, and long-term client retention.

We’re here in Las Vegas talking with teams about how body composition and fluid data can support that shift.

If you’re attending, come see us at Booth 1011—or reach out to connect while you’re here:
🔗 https://www.impedimed.com/about/contact/

04/10/2026

Obesity medicine is evolving—and so is how we define progress.

At , the conversation goes beyond weight alone, with more focus on body composition, fluid status, and how patients are actually responding to treatment over time.

We’re here in San Diego and would love to connect.

📍 Booth 203 | April 10–12

Want to connect while you’re here? Reach out and we’ll find time: https://www.impedimed.com/about/contact/

04/08/2026

What happens when weight loss doesn’t tell the full story?

In this case, a 59-year-old patient on GLP-1/GIP therapy showed steady weight loss over six months. But body composition told a different story.

Early on, skeletal muscle mass increased and fat mass decreased. By months 4–5, that trend reversed—muscle declined while fat mass increased—before stabilizing again with intervention.

The scale showed progress. The body showed something different.

This is exactly the kind of conversation we’re having with clinicians and practices across the country this week—how to better understand what’s actually changing during treatment, and how to act on it earlier.

—
Find us this week:

📍 Obesity Medicine 2026 | San Diego, CA | April 10–12 | Booth 203

📍 Medical Spa Show 2026 | Las Vegas, NV | April 9–12 | Booth 1011

—
If you’re attending, we’d love to connect. If not, or if you’d like to schedule time during the event, reach out here:
🔗 https://www.impedimed.com/about/contact/

04/07/2026

Today, we’re excited to welcome Erik Anderson as CEO and Managing Director of ImpediMed.

Over the past two years, we’ve focused on building the foundation — expanding reimbursement coverage for lymphedema surveillance across 93% of covered lives in the US and expanding clinical indications in body composition and heart health.

Erik’s appointment reflects where we’re focused next: stronger commercial ex*****on in the US and continued adoption of the SOZO Digital Health Platform across indications.

He brings deep experience across US health systems, clinical adoption, and reimbursement — all critical as we continue expanding access.

Read the full announcement: https://www.impedimed.com/impedimed-appoints-erik-anderson-as-chief-executive-officer/.

04/01/2026

Survivors can look stable — and still be changing underneath.

Changes in fluid balance, muscle mass, and functional reserve often develop gradually, and long before symptoms appear.

In her latest article in HealthcareNOWradio, Erin Dickman, DNP, RN, OCN, explores why survivorship care must evolve beyond episodic follow-ups toward longitudinal, whole-body monitoring — and the critical role nurses play in making that shift possible.

Read the full article to see how nurses can lead this shift in long-term survivorship care: https://www.impedimed.com/why-long-term-survivorship-demands-longitudinal-monitoring/

03/31/2026

As Lymphedema Awareness Month comes to a close, one thing remains constant:

Cancer care doesn’t end when treatment does.

Survivorship isn’t defined by a single complication. It’s the full picture of how the body changes over time.

Lymphedema is part of that story — but so are fluid shifts, muscle changes, and physiological trends that aren’t always visible in routine exams.

That’s why structured survivorship care matters.

• Establishing baseline data
• Monitoring objectively over time
• Detecting meaningful change earlier
• Turning insight into action

Because long-term outcomes depend on what we measure — and what we do next.

Address

Carlsbad, CA
92008

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+17605852100

Website

http://www.impedimed.com/

Alerts

Be the first to know and let us send you an email when ImpediMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ImpediMed:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Carlsbad?